The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis.

Graham Bothamley; (2017) The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis. Breathe (Sheffield, England), 13 (3). e65-e71. ISSN 1810-6838 DOI: 10.1183/20734735.005517
Copy

UNLABELLED: The Tuberculosis Network European Trials Group (TBNET) is the largest clinical research organisation in Europe. Educational activities include the TBNET Academy and the European Advanced Course in Clinical Tuberculosis. Four of their publications are reviewed to show how the clinical management of tuberculosis is changing. KEY POINTS: Most tuberculosis (TB) in contacts is found at their first visit.In contacts of pulmonary TB patients, the likelihood of later TB is ≤3%.Genetic tests can indicate when another antimycobacterial drug in the same class might be effective (e.g. rifabutin when there is rifampicin resistance or which injectable to choose).The short-course "Bangladesh" regimen can only be rarely used in Europe.Treatment completion in multidrug-resistant TB should not be included as a successful outcome.

Full text not available from this repository.

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads